Solving the Diagnostic Puzzle
At a Glance
HHH syndrome is confirmed by finding two disease-causing or likely disease-causing variants in the SLC25A15 gene, one inherited from each parent. Blood and urine markers support the diagnosis but may be normal or absent between metabolic crises.
Confirming a diagnosis of HHH syndrome can be a complex puzzle. Because the condition is so rare, doctors look for a specific biochemical pattern—three specific markers in the blood and urine—but it is common for one or more of these markers to be missing or subtle, especially between metabolic crises [1][2].
The Variable Biochemical Pattern (The Triad)
A “classic” HHH diagnosis involves finding three specific abnormalities, though they do not always appear at the same time:
- Hyperornithinemia (High Blood Ornithine): This is often the most consistent marker. Ornithine levels build up because they cannot enter the mitochondria [2]. However, what is considered “high” can vary by lab, and some patients may have levels that only slightly overlap the normal range [3].
- Hyperammonemia (High Blood Ammonia): Ammonia is a toxin that should be cleared by the urea cycle. While levels can skyrocket during a crisis (reaching over 1,000 μmol/L in some newborns), they can also be completely normal when a patient is feeling well. A normal ammonia result during wellness does not exclude HHH [4][3].
- Homocitrullinuria (Homocitrulline in Urine): This is a unique chemical created when the urea cycle is impaired in HHH. While it is a very strong sign of the disease, it is frequently absent. In one small study of four children with confirmed HHH, none had detectable homocitrulline in their urine [2].
Why Diagnosis Can Be Delayed
Because the markers mentioned above can be “intermittent” (coming and going), many patients face a long “diagnostic odyssey.” A doctor might test a child’s ammonia when they are healthy and find a normal result, accidentally ruling out a urea cycle disorder [5].
Additionally, HHH can “mimic” other conditions. For example, it causes a stiff way of walking (spastic paraplegia) that is also seen in argininemia (another metabolic disorder) or P5CS deficiency [6][7]. Another marker, orotic acid, may be elevated in the urine of HHH patients, but this also happens in a more common disorder called OTC deficiency [3][8].
The Role of Genetic Testing
Because blood and urine tests can be inconclusive, molecular genetic testing is critical for confirming the diagnosis [9].
- The Gene: Doctors look for variants in the SLC25A15 gene.
- Biallelic Variants: To have HHH syndrome, a person must have two pathogenic (disease-causing) or likely pathogenic variants in trans—one inherited from each parent [9][10].
- Interpretation: A “variant of uncertain significance” (VUS) does not establish a diagnosis. However, genetic testing can definitively confirm HHH when two pathogenic variants are found, even if the urine homocitrulline is zero and the ammonia is normal at the time of the test [3].
Your Diagnostic Checklist
To ensure your care team has the full picture, you should keep a record of the following results:
| Test Category | What to Look For | Why It Matters |
|---|---|---|
| Plasma Amino Acids | Elevated Ornithine | Suggests the “shuttle” is impaired [2]. |
| Blood Ammonia | Elevated Ammonia | Measures the immediate risk of brain toxicity; requires urgent collection/handling [4]. |
| Urine Amino Acids (or targeted method) | Elevated Homocitrulline | Supportive evidence, even if often absent. Do not rely on organic acid tests for this [1]. |
| Urine Organic Acids | Elevated Orotic Acid | Supportive evidence that helps rule out other conditions [1]. |
| Genetic Report | Two pathogenic variants in SLC25A15 | The standard to definitively “name” the condition [9]. |
Having these documents ready is vital, especially if you need to visit an emergency room where the doctors are unfamiliar with your specific metabolic needs.
Common questions in this guide
How is HHH syndrome definitively diagnosed?
Can a normal ammonia level rule out HHH syndrome?
What does a high ornithine level mean in HHH syndrome?
Is homocitrulline required to diagnose HHH syndrome?
How is HHH syndrome distinguished from similar metabolic disorders?
What does a variant of uncertain significance mean in SLC25A15 testing?
Get notified when new evidence is published on Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (10)
- 1
The hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.
Martinelli D, Diodato D, Ponzi E, et al.
Orphanet journal of rare diseases 2015; (10()):29 doi:10.1186/s13023-015-0242-9.
PMID: 25874378 - 2
Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome in Vietnamese Patients.
Nguyen KN, Tran VK, Nguyen NL, et al.
Medicina (Kaunas, Lithuania) 2024; (60(11)) doi:10.3390/medicina60111877.
PMID: 39597062 - 3
[Clinical diagnosis and treatment of three cases with hyperornithinemia-hyperammonemia-homocitrullinuria syndrome].
Guan HZ, Ding Y, Li DX, et al.
Zhonghua er ke za zhi = Chinese journal of pediatrics 2017; (55(6)):428-433 doi:10.3760/cma.j.issn.0578-1310.2017.06.007.
PMID: 28592010 - 4
Hyperornithinemia, Hyperammonemia, and Homocitrullinuria Syndrome Causing Severe Neonatal Hyperammonemia.
Wild KT, Ganetzky RD, Yudkoff M, Ierardi-Curto L
JIMD reports 2019; (44()):103-107 doi:10.1007/8904_2018_132.
PMID: 30187369 - 5
Hyperornithinemia-hyperammonemia-homocitrullinuria: a rare neurometabolic disorder in two siblings.
Rizkallah D, Daher RT, Haddad L, Karam PE
Metabolic brain disease 2024; (39(5)):909-913 doi:10.1007/s11011-024-01366-z.
PMID: 38833093 - 6
Corticospinal tract damage in HHH syndrome: a metabolic cause of hereditary spastic paraplegia.
Olivieri G, Pro S, Diodato D, et al.
Orphanet journal of rare diseases 2019; (14(1)):208 doi:10.1186/s13023-019-1181-7.
PMID: 31443672 - 7
Hereditary Spastic Paraplegia Is a Common Phenotypic Finding in ARG1 Deficiency, P5CS Deficiency and HHH Syndrome: Three Inborn Errors of Metabolism Caused by Alteration of an Interconnected Pathway of Glutamate and Urea Cycle Metabolism.
Panza E, Martinelli D, Magini P, et al.
Frontiers in neurology 2019; (10()):131 doi:10.3389/fneur.2019.00131.
PMID: 30853934 - 8
Improving long term outcomes in urea cycle disorders-report from the Urea Cycle Disorders Consortium.
Waisbren SE, Gropman AL, , Batshaw ML
Journal of inherited metabolic disease 2016; (39(4)):573-84 doi:10.1007/s10545-016-9942-0.
PMID: 27215558 - 9
Clinical heterogeneity of hyperornithinemia-hyperammonemia-homocitrullinuria syndrome in thirteen palestinian patients and report of a novel variant in the SLC25A15 gene.
Dweikat I, Khalaf-Nazzal R
Frontiers in genetics 2022; (13()):1004598 doi:10.3389/fgene.2022.1004598.
PMID: 36506307 - 10
Late onset hyperornithinemia-hyperammonemia-homocitrullinuria syndrome - how web searching by the family solved unexplained unconsciousness: a case report.
Silfverberg T, Sahlander F, Enlund M, et al.
Journal of medical case reports 2018; (12(1)):274 doi:10.1186/s13256-018-1794-9.
PMID: 30243302
This page explains how HHH syndrome is evaluated for educational purposes and does not replace medical advice. A metabolic specialist or genetic professional should interpret your results and guide care.